LEADER 01125nlm  2200325 a 450 
001 996471472803316
005 20220516081733.0
010   $a1-58983-008-3
100   $a20010501d2001----  uy             0
101 0 $aeng
102   $aUS
135   $adrcnu
200 1 $aFlavius Philostratus: Heroikos$ftranslated with an introduction and notes by Jennifer K. Berenson Maclean and Ellen Bradshaw Aitken$gwith a prologue by Gregory Nagy and an epilogue by Helmut Koester
210 1 $aAtlanta$cSociety of Biblical Literature$d2001
215   $aTesto elettronico (PDF) (XCVII, 318 p.)$cill.
225 2 $aWritings from the Greco-Roman world$v1
225 2 $aACLS Humanities E-Book
230   $aBase dati testuale
410  0$aWritings from the Greco-Roman world$v1
410  0$aACLS Humanities E-Book
676   $a882.01
700  1$aPHILOSTRATUS,$bFlavius$0207827
702  1$aAITKEN,$bEllen Bradshaw
702  1$aMACLEAN,$bJennifer K. Berenson
801  0$aIT$bcba$cREICAT
912   $a996471472803316
959   $aEB
969   $aER
996   $aFlavius Philostratus: Heroikos$92838437
997   $aUNISA

LEADER 02556nam  2200553Ia 450 
001 9910780304003321
005 20230607214358.0
010   $a92-4-068069-1
035   $a(CKB)111087028329462
035   $a(EBL)284606
035   $a(OCoLC)476034703
035   $a(SSID)ssj0000173793
035   $a(PQKBManifestationID)11176938
035   $a(PQKBTitleCode)TC0000173793
035   $a(PQKBWorkID)10185451
035   $a(PQKB)11300191
035   $a(MiAaPQ)EBC284606
035   $a(Au-PeEL)EBL284606
035   $a(CaPaEBR)ebr10062381
035   $a(EXLCZ)99111087028329462
100   $a20020404d2001      uf             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHow to develop and implement a national drug policy$b[electronic resource]
205   $a2nd ed.
210   $aGeneva $cWorld Health Organization$dc2001
215   $a1 online resource (96 p.)
300   $aUpdates and replaces Guidelines for developing national drug policies, 1988.
311   $a0-585-47315-3 
311   $a92-4-154547-X 
320   $aIncludes bibliographical references.
327   $aContents; Contributors; Abbreviations and acronyms; Preface; 1. Introduction; 2. The national drug policy process; 3. Legislation; 4. Selection of essential drugs; 5. Affordability; 6. Drug financing; 7. Supply systems; 8. Drug regulation; 9. Rational use of drugs; 10. Research; 11. Human resources development; 12. Monitoring and evaluation; References
330   $aIn Europe today, HIV/AIDS prevention, treatment and care are needed more than ever. HIV incidence steady in western and central Europe, and dramatically increasing in eastern Europe remains a major challenge to public health in the 21st century. With more than two million people living with HIV/AIDS in the WHO European Region, no country has been spared. This book tells the story of HIV/AIDS in Europe from a broad variety of perspectives: biomedical, social, cultural, economic and political. The authors are leading experts from across the Region and include both the infected and the affected,
606   $aPharmaceutical policy
606   $aDrug utilization
615  0$aPharmaceutical policy.
615  0$aDrug utilization.
676   $a362.1/782
712 02$aWorld Health Organization
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910780304003321
996   $aHow to develop and implement a national drug policy$93671516
997   $aUNINA